Since CD38 is part of the purinergic-signaling cascade that converts NAD+ into immunosuppressive adenosine, the overexpression of CD38 on tumor cells is thought to contribute to an anti-inflammatory tumor microenvironment (21, 22). The gene discussed is CD38; the disease is neoplasm.